Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
University of California, San Diego
Cambridge University Hospitals NHS Foundation Trust
Centre Antoine Lacassagne
National Cancer Institute (NCI)
National Taiwan University Hospital
Jules Bordet Institute
University Health Network, Toronto
University of Arizona
University Hospital, Montpellier
Albert Einstein College of Medicine
LifeCell
Abramson Cancer Center at Penn Medicine
Xiangya Hospital of Central South University
Children's Oncology Group
Boston Medical Center
Assiut University
University of Michigan Rogel Cancer Center
Washington University School of Medicine
AHS Cancer Control Alberta
Guy's and St Thomas' NHS Foundation Trust
Air Force Military Medical University, China
University of Michigan Rogel Cancer Center
London Health Sciences Centre
Abramson Cancer Center at Penn Medicine